Summary: <p>CME credits: 0.50 Valid until: 12/31/2014 Claim your CME credit at http://www.reachmd.com/cmedetails.aspx?sid=6857</p><p>Noninvasive prenatal screening utilizing DNA technology offers tremendous potential as a screening tool for fetal aneuploidy. Both ACOG and ACMG have recently published guidelines surrounding the use of NIPS. Please join Dr. Susan Gross as she explains the benefits and limitations of NIPS and diagnostic testing options.</p> <p><strong>Estimated time to complete activity:</strong> 30 minutes</p>
